

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * exogenous drug catabolic process (GO:0042738) | 8.29466945 |
| 2 | * drug catabolic process (GO:0042737) | 7.81586649 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63498017 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.63498017 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25094396 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.25094396 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.90091353 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.21824955 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.21824955 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.21824955 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.10140356 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.06224313 |
| 13 | * epoxygenase P450 pathway (GO:0019373) | 6.05619549 |
| 14 | bile acid biosynthetic process (GO:0006699) | 6.02874103 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.88220144 |
| 16 | S-adenosylmethionine metabolic process (GO:0046500) | 5.85295635 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.68640220 |
| 18 | urea metabolic process (GO:0019627) | 5.65815420 |
| 19 | urea cycle (GO:0000050) | 5.65815420 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.53197965 |
| 21 | ethanol metabolic process (GO:0006067) | 5.42509090 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.39678846 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.37259267 |
| 24 | protein carboxylation (GO:0018214) | 5.36462643 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.36462643 |
| 26 | cysteine metabolic process (GO:0006534) | 5.35770593 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.32521777 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 5.27803179 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.24253265 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.20861769 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.19029787 |
| 32 | bile acid metabolic process (GO:0008206) | 5.16048755 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.03158641 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 5.00414353 |
| 35 | cellular glucuronidation (GO:0052695) | 4.97568976 |
| 36 | * oxidative demethylation (GO:0070989) | 4.95276395 |
| 37 | flavonoid metabolic process (GO:0009812) | 4.94966101 |
| 38 | regulation of complement activation (GO:0030449) | 4.89462533 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.82531460 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.77661106 |
| 41 | lysine metabolic process (GO:0006553) | 4.74034017 |
| 42 | lysine catabolic process (GO:0006554) | 4.74034017 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.71345775 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.70356519 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.65923863 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.63761097 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.62295002 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.54038230 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.54038230 |
| 50 | macromolecular complex remodeling (GO:0034367) | 4.54038230 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.51365344 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.48930323 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.47695886 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.47695886 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.46985016 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.46985016 |
| 57 | glucuronate metabolic process (GO:0019585) | 4.46104777 |
| 58 | uronic acid metabolic process (GO:0006063) | 4.46104777 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.42151740 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.41957015 |
| 61 | glycine metabolic process (GO:0006544) | 4.39084869 |
| 62 | benzene-containing compound metabolic process (GO:0042537) | 4.32723414 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 4.31924564 |
| 64 | amine catabolic process (GO:0009310) | 4.31043765 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 4.31043765 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 4.27983279 |
| 67 | glutamate metabolic process (GO:0006536) | 4.26639530 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.23927789 |
| 69 | phospholipid efflux (GO:0033700) | 4.22300273 |
| 70 | xenobiotic catabolic process (GO:0042178) | 4.19079585 |
| 71 | serine family amino acid metabolic process (GO:0009069) | 4.18347994 |
| 72 | aldehyde catabolic process (GO:0046185) | 4.14506027 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.13038687 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 4.12971094 |
| 75 | * drug metabolic process (GO:0017144) | 4.08177246 |
| 76 | ethanol oxidation (GO:0006069) | 4.07764024 |
| 77 | arginine metabolic process (GO:0006525) | 4.03630949 |
| 78 | cholesterol efflux (GO:0033344) | 4.01448087 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 4.01327237 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00882272 |
| 81 | fibrinolysis (GO:0042730) | 3.93254210 |
| 82 | cofactor catabolic process (GO:0051187) | 3.91613025 |
| 83 | regulation of bile acid biosynthetic process (GO:0070857) | 3.89654356 |
| 84 | blood coagulation, intrinsic pathway (GO:0007597) | 3.81425609 |
| 85 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.80055392 |
| 86 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.80055392 |
| 87 | low-density lipoprotein particle remodeling (GO:0034374) | 3.76901097 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.76598441 |
| 89 | organic acid catabolic process (GO:0016054) | 3.75642162 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 3.75642162 |
| 91 | * omega-hydroxylase P450 pathway (GO:0097267) | 3.74792274 |
| 92 | complement activation, classical pathway (GO:0006958) | 3.73031707 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 3.71491408 |
| 94 | opsonization (GO:0008228) | 3.71419840 |
| 95 | short-chain fatty acid metabolic process (GO:0046459) | 3.71399398 |
| 96 | complement activation (GO:0006956) | 3.70121584 |
| 97 | protein activation cascade (GO:0072376) | 3.67509445 |
| 98 | ketone body metabolic process (GO:1902224) | 3.66434904 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.66234918 |
| 100 | acetyl-CoA metabolic process (GO:0006084) | 3.66052924 |
| 101 | cytolysis (GO:0019835) | 3.65813661 |
| 102 | phenylpropanoid metabolic process (GO:0009698) | 3.65316832 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.65050927 |
| 104 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.63461160 |
| 105 | L-methionine salvage (GO:0071267) | 3.63232563 |
| 106 | L-methionine biosynthetic process (GO:0071265) | 3.63232563 |
| 107 | amino acid salvage (GO:0043102) | 3.63232563 |
| 108 | response to nitrosative stress (GO:0051409) | 3.61344157 |
| 109 | sterol homeostasis (GO:0055092) | 3.60191795 |
| 110 | phospholipid homeostasis (GO:0055091) | 3.58416367 |
| 111 | sodium-independent organic anion transport (GO:0043252) | 3.57328642 |
| 112 | regulation of plasminogen activation (GO:0010755) | 3.56922910 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.54249408 |
| 114 | aspartate family amino acid catabolic process (GO:0009068) | 3.53644266 |
| 115 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.51704991 |
| 116 | behavioral response to nicotine (GO:0035095) | 3.38423840 |
| 117 | heme transport (GO:0015886) | 3.35662979 |
| 118 | negative regulation of protein activation cascade (GO:2000258) | 3.35484182 |
| 119 | regulation of hexokinase activity (GO:1903299) | 3.32210229 |
| 120 | regulation of glucokinase activity (GO:0033131) | 3.32210229 |
| 121 | intestinal cholesterol absorption (GO:0030299) | 3.25011006 |
| 122 | * xenobiotic metabolic process (GO:0006805) | 3.22961050 |
| 123 | positive regulation of fatty acid transport (GO:2000193) | 3.21003430 |
| 124 | negative regulation of hemostasis (GO:1900047) | 3.19167310 |
| 125 | negative regulation of blood coagulation (GO:0030195) | 3.19167310 |
| 126 | nucleobase catabolic process (GO:0046113) | 3.18342364 |
| 127 | regulation of humoral immune response (GO:0002920) | 3.16174800 |
| 128 | urate metabolic process (GO:0046415) | 3.15356241 |
| 129 | positive regulation of icosanoid secretion (GO:0032305) | 3.14298701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.37823405 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.12476728 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.05907666 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48258320 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.30023065 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.04987216 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.74611238 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05471545 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.95466792 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.93690585 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.63167383 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.45670100 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.36576385 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10064921 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09147035 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9595866 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.94538663 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.94533921 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93523493 |
| 20 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91563921 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91488440 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.91139920 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85242883 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.84622384 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67176042 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.65680170 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57675709 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57364319 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56924792 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56648196 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.55553062 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.55004328 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52003851 |
| 34 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.51909312 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.51497396 |
| 36 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.48767549 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48242495 |
| 38 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.45881848 |
| 39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.45043904 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44722019 |
| 41 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.42296837 |
| 42 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42296837 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40387125 |
| 44 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38777247 |
| 45 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.37723626 |
| 46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36273603 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35561956 |
| 48 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34720252 |
| 49 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.34044152 |
| 50 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.34044152 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31711222 |
| 52 | TCF4_23295773_ChIP-Seq_U87_Human | 1.30854440 |
| 53 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.30227871 |
| 54 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.30227871 |
| 55 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.27145624 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26178950 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25691124 |
| 58 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25122286 |
| 59 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.22717654 |
| 60 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.22403693 |
| 61 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22363725 |
| 62 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21776087 |
| 63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21750798 |
| 64 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21313859 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20845490 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20353375 |
| 67 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19922799 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18317061 |
| 69 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18155731 |
| 70 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17836538 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17131018 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17079667 |
| 73 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.16895137 |
| 74 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16459225 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15050296 |
| 76 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14789555 |
| 77 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13097795 |
| 78 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12708564 |
| 79 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12499807 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11892641 |
| 81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09683018 |
| 82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09683018 |
| 83 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.09159851 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08470381 |
| 85 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.08076791 |
| 86 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08025384 |
| 87 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.05503188 |
| 88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05500469 |
| 89 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.05160426 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04118554 |
| 91 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02449104 |
| 92 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02004961 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00439271 |
| 94 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99851372 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98380149 |
| 96 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98246870 |
| 97 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97853533 |
| 98 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.97569276 |
| 99 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97542898 |
| 100 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.97237054 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93858390 |
| 102 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93055886 |
| 103 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87162315 |
| 104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86548869 |
| 105 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81341792 |
| 106 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80436359 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80144602 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79574826 |
| 109 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79224979 |
| 110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77223420 |
| 111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73697206 |
| 112 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.73199892 |
| 113 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.72955167 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72571819 |
| 115 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72281333 |
| 116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71263152 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70614578 |
| 118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70614578 |
| 119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70080080 |
| 120 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.69841076 |
| 121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.69524525 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69410717 |
| 123 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67341070 |
| 124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66985800 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63042169 |
| 126 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62410485 |
| 127 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.61875531 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61540452 |
| 129 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.60987822 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60202822 |
| 131 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60168695 |
| 132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58683872 |
| 133 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56502927 |
| 134 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.54588807 |
| 135 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52864751 |
| 136 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52576178 |
| 137 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52462177 |
| 138 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51777676 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.51201514 |
| 140 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50384963 |
| 141 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49578033 |
| 142 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49139929 |
| 143 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.49007120 |
| 144 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48843969 |
| 145 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.48370965 |
| 146 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47970347 |
| 147 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.47079002 |
| 148 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.46943224 |
| 149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46483045 |
| 150 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46072607 |
| 151 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43607401 |
| 152 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43127877 |
| 153 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41228786 |
| 154 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40665705 |
| 155 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40552817 |
| 156 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40454982 |
| 157 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39633795 |
| 158 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39622074 |
| 159 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39608024 |
| 160 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39554445 |
| 161 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39015733 |
| 162 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.38479065 |
| 163 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38184038 |
| 164 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37122428 |
| 165 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.36829574 |
| 166 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36809683 |
| 167 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.36482050 |
| 168 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36074286 |
| 169 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35924032 |
| 170 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35184390 |
| 171 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.34407739 |
| 172 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.33971900 |
| 173 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.33682468 |
| 174 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.33440559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.35309275 |
| 2 | MP0005360_urolithiasis | 7.51511099 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.49755499 |
| 4 | MP0005365_abnormal_bile_salt | 6.15621385 |
| 5 | * MP0008875_abnormal_xenobiotic_pharmacok | 5.98083944 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.24003793 |
| 7 | MP0003252_abnormal_bile_duct | 3.91268072 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.50778501 |
| 9 | MP0009840_abnormal_foam_cell | 3.04182953 |
| 10 | MP0005083_abnormal_biliary_tract | 2.96612693 |
| 11 | MP0003195_calcinosis | 2.84369466 |
| 12 | MP0005332_abnormal_amino_acid | 2.74912150 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.56891906 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.14567827 |
| 15 | * MP0000609_abnormal_liver_physiology | 2.11641034 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.06073288 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 1.99325510 |
| 18 | MP0003868_abnormal_feces_composition | 1.92588774 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.89524862 |
| 20 | * MP0005319_abnormal_enzyme/_coenzyme | 1.85015418 |
| 21 | MP0001764_abnormal_homeostasis | 1.69263345 |
| 22 | MP0006292_abnormal_olfactory_placode | 1.63014820 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59585071 |
| 24 | MP0005551_abnormal_eye_electrophysiolog | 1.58279608 |
| 25 | MP0009697_abnormal_copulation | 1.51543839 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.41169995 |
| 27 | MP0001986_abnormal_taste_sensitivity | 1.40375569 |
| 28 | MP0005451_abnormal_body_composition | 1.35964490 |
| 29 | MP0003011_delayed_dark_adaptation | 1.35500706 |
| 30 | MP0002234_abnormal_pharynx_morphology | 1.33789028 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.32859538 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.30971246 |
| 33 | MP0004142_abnormal_muscle_tone | 1.30779764 |
| 34 | MP0003186_abnormal_redox_activity | 1.30374968 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.23235890 |
| 36 | MP0009764_decreased_sensitivity_to | 1.20244927 |
| 37 | MP0002102_abnormal_ear_morphology | 1.19981568 |
| 38 | * MP0000598_abnormal_liver_morphology | 1.16737296 |
| 39 | MP0003136_yellow_coat_color | 1.12512897 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.11940443 |
| 41 | MP0005647_abnormal_sex_gland | 1.10225839 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.02312784 |
| 43 | MP0004133_heterotaxia | 0.99897081 |
| 44 | MP0000604_amyloidosis | 0.99604715 |
| 45 | MP0009763_increased_sensitivity_to | 0.99469351 |
| 46 | * MP0009745_abnormal_behavioral_response | 0.99462641 |
| 47 | MP0002254_reproductive_system_inflammat | 0.98141666 |
| 48 | MP0003646_muscle_fatigue | 0.96231866 |
| 49 | MP0004043_abnormal_pH_regulation | 0.96097869 |
| 50 | MP0002638_abnormal_pupillary_reflex | 0.94700588 |
| 51 | MP0010368_abnormal_lymphatic_system | 0.94529508 |
| 52 | MP0002736_abnormal_nociception_after | 0.92507441 |
| 53 | MP0009765_abnormal_xenobiotic_induced | 0.90722878 |
| 54 | MP0005408_hypopigmentation | 0.89138434 |
| 55 | MP0003787_abnormal_imprinting | 0.87912881 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 0.87134891 |
| 57 | MP0002282_abnormal_trachea_morphology | 0.86786267 |
| 58 | MP0005670_abnormal_white_adipose | 0.86658514 |
| 59 | * MP0008469_abnormal_protein_level | 0.86048568 |
| 60 | * MP0009642_abnormal_blood_homeostasis | 0.85018335 |
| 61 | MP0000372_irregular_coat_pigmentation | 0.84009921 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 0.83262903 |
| 63 | MP0005376_homeostasis/metabolism_phenot | 0.81200384 |
| 64 | MP0005187_abnormal_penis_morphology | 0.81197421 |
| 65 | MP0004885_abnormal_endolymph | 0.79015073 |
| 66 | MP0001501_abnormal_sleep_pattern | 0.78175927 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 0.76204666 |
| 68 | MP0002272_abnormal_nervous_system | 0.75805762 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.75352065 |
| 70 | MP0001485_abnormal_pinna_reflex | 0.73121572 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 0.73008738 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.72945873 |
| 73 | MP0005253_abnormal_eye_physiology | 0.72584600 |
| 74 | MP0005266_abnormal_metabolism | 0.70829935 |
| 75 | MP0001984_abnormal_olfaction | 0.70613140 |
| 76 | MP0003880_abnormal_central_pattern | 0.69997891 |
| 77 | MP0002653_abnormal_ependyma_morphology | 0.69057350 |
| 78 | MP0003690_abnormal_glial_cell | 0.69028365 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 0.68288232 |
| 80 | MP0004130_abnormal_muscle_cell | 0.68169382 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 0.67960345 |
| 82 | MP0000427_abnormal_hair_cycle | 0.67699084 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.67298395 |
| 84 | MP0009046_muscle_twitch | 0.66318256 |
| 85 | MP0009053_abnormal_anal_canal | 0.65414928 |
| 86 | MP0005334_abnormal_fat_pad | 0.64962892 |
| 87 | MP0002971_abnormal_brown_adipose | 0.64822779 |
| 88 | MP0002938_white_spotting | 0.63923464 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.63736409 |
| 90 | MP0003878_abnormal_ear_physiology | 0.63318836 |
| 91 | MP0005377_hearing/vestibular/ear_phenot | 0.63318836 |
| 92 | MP0003329_amyloid_beta_deposits | 0.61448197 |
| 93 | MP0000569_abnormal_digit_pigmentation | 0.60973644 |
| 94 | * MP0005535_abnormal_body_temperature | 0.60780224 |
| 95 | MP0002735_abnormal_chemical_nociception | 0.60600611 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.60565532 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.59589931 |
| 98 | MP0004924_abnormal_behavior | 0.59589931 |
| 99 | MP0002064_seizures | 0.59544744 |
| 100 | MP0003879_abnormal_hair_cell | 0.58861320 |
| 101 | MP0005195_abnormal_posterior_eye | 0.58573708 |
| 102 | MP0001486_abnormal_startle_reflex | 0.58176804 |
| 103 | * MP0008874_decreased_physiological_sensi | 0.57840123 |
| 104 | MP0000639_abnormal_adrenal_gland | 0.57230450 |
| 105 | MP0001661_extended_life_span | 0.56438810 |
| 106 | MP0002822_catalepsy | 0.56262685 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.56192002 |
| 108 | MP0001756_abnormal_urination | 0.56139061 |
| 109 | MP0008873_increased_physiological_sensi | 0.56041862 |
| 110 | MP0001440_abnormal_grooming_behavior | 0.55554459 |
| 111 | MP0004147_increased_porphyrin_level | 0.55526381 |
| 112 | MP0001502_abnormal_circadian_rhythm | 0.54692113 |
| 113 | * MP0008872_abnormal_physiological_respon | 0.51765540 |
| 114 | MP0005448_abnormal_energy_balance | 0.50546543 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.47482404 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.45868414 |
| 117 | MP0003718_maternal_effect | 0.45299913 |
| 118 | MP0002928_abnormal_bile_duct | 0.44493768 |
| 119 | MP0005395_other_phenotype | 0.44230072 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.43386241 |
| 121 | MP0003075_altered_response_to | 0.43059897 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.42175028 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.41906227 |
| 124 | MP0004381_abnormal_hair_follicle | 0.39335738 |
| 125 | MP0003436_decreased_susceptibility_to | 0.38923699 |
| 126 | MP0009672_abnormal_birth_weight | 0.38796769 |
| 127 | MP0003953_abnormal_hormone_level | 0.38263176 |
| 128 | MP0005166_decreased_susceptibility_to | 0.36241059 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.36108152 |
| 130 | MP0000579_abnormal_nail_morphology | 0.35656635 |
| 131 | MP0003724_increased_susceptibility_to | 0.34020511 |
| 132 | MP0002090_abnormal_vision | 0.31188598 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.31073684 |
| 134 | MP0002796_impaired_skin_barrier | 0.30118100 |
| 135 | MP0009115_abnormal_fat_cell | 0.29636055 |
| 136 | MP0006082_CNS_inflammation | 0.29619350 |
| 137 | MP0000249_abnormal_blood_vessel | 0.29464467 |
| 138 | MP0001243_abnormal_dermal_layer | 0.28812817 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.28676822 |
| 140 | MP0002970_abnormal_white_adipose | 0.27398523 |
| 141 | MP0002168_other_aberrant_phenotype | 0.27130595 |
| 142 | MP0001881_abnormal_mammary_gland | 0.26820650 |
| 143 | MP0002132_abnormal_respiratory_system | 0.25473323 |
| 144 | MP0001853_heart_inflammation | 0.24879304 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.24441209 |
| 146 | MP0002060_abnormal_skin_morphology | 0.24204660 |
| 147 | MP0004883_abnormal_blood_vessel | 0.23488727 |
| 148 | MP0005058_abnormal_lysosome_morphology | 0.23139548 |
| 149 | MP0002135_abnormal_kidney_morphology | 0.20571988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.58604733 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.51527763 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.34883921 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.80186021 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.68527102 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.45928757 |
| 7 | Xanthomatosis (HP:0000991) | 6.18108581 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.76440523 |
| 9 | Complement deficiency (HP:0004431) | 5.35433633 |
| 10 | Joint hemorrhage (HP:0005261) | 4.79996725 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.74511353 |
| 12 | Hyperammonemia (HP:0001987) | 4.61856868 |
| 13 | Epidermoid cyst (HP:0200040) | 4.57913746 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.37231021 |
| 15 | Hyperglycinemia (HP:0002154) | 4.34415846 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.33398630 |
| 17 | Ketosis (HP:0001946) | 4.32276338 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.32192896 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27170095 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.23973462 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13927124 |
| 22 | Fat malabsorption (HP:0002630) | 4.10049171 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.09142131 |
| 24 | Hyperglycinuria (HP:0003108) | 4.03609113 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.97404913 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.97404913 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.94152617 |
| 28 | Abnormality of complement system (HP:0005339) | 3.90368503 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85231839 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.78239343 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.72658178 |
| 32 | Fair hair (HP:0002286) | 3.62076706 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.61021724 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37899474 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.37781970 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31752971 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.19948612 |
| 38 | Steatorrhea (HP:0002570) | 3.16974245 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10129762 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.04262825 |
| 41 | Pancreatic cysts (HP:0001737) | 3.02692184 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.98975374 |
| 43 | Ketoacidosis (HP:0001993) | 2.95825161 |
| 44 | Myocardial infarction (HP:0001658) | 2.94018500 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.91780974 |
| 46 | Pancreatic fibrosis (HP:0100732) | 2.89007717 |
| 47 | Skin nodule (HP:0200036) | 2.88455674 |
| 48 | Chronic hepatic failure (HP:0100626) | 2.86158789 |
| 49 | Spontaneous abortion (HP:0005268) | 2.78658344 |
| 50 | Metabolic acidosis (HP:0001942) | 2.77112715 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.76819305 |
| 52 | Abnormal biliary tract physiology (HP:0012439) | 2.75675011 |
| 53 | Bile duct proliferation (HP:0001408) | 2.75675011 |
| 54 | True hermaphroditism (HP:0010459) | 2.69518080 |
| 55 | Neonatal hypoglycemia (HP:0001998) | 2.69380465 |
| 56 | Generalized hypopigmentation of hair (HP:0011358) | 2.68909905 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.68118334 |
| 58 | Lethargy (HP:0001254) | 2.63056644 |
| 59 | Abnormality of midbrain morphology (HP:0002418) | 2.61622029 |
| 60 | Molar tooth sign on MRI (HP:0002419) | 2.61622029 |
| 61 | Congenital stationary night blindness (HP:0007642) | 2.58195286 |
| 62 | Spastic diplegia (HP:0001264) | 2.57774343 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55921300 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.55921300 |
| 65 | Vascular calcification (HP:0004934) | 2.49383177 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 2.48198219 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 2.46605761 |
| 68 | Gout (HP:0001997) | 2.45065285 |
| 69 | Cerebral edema (HP:0002181) | 2.43903785 |
| 70 | Mitral stenosis (HP:0001718) | 2.42552205 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41976903 |
| 72 | Neonatal onset (HP:0003623) | 2.41766972 |
| 73 | Decreased central vision (HP:0007663) | 2.41139033 |
| 74 | Cholelithiasis (HP:0001081) | 2.40749658 |
| 75 | Irritability (HP:0000737) | 2.39041771 |
| 76 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.38993536 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 2.38993536 |
| 78 | Hyperalaninemia (HP:0003348) | 2.38993536 |
| 79 | Acanthocytosis (HP:0001927) | 2.37734594 |
| 80 | Glomerulonephritis (HP:0000099) | 2.37391304 |
| 81 | Hypoglycemic seizures (HP:0002173) | 2.34149685 |
| 82 | Hyperventilation (HP:0002883) | 2.29650752 |
| 83 | Brushfield spots (HP:0001088) | 2.21914544 |
| 84 | Cardiovascular calcification (HP:0011915) | 2.21166082 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.19825123 |
| 86 | Cholecystitis (HP:0001082) | 2.19825123 |
| 87 | Type II lissencephaly (HP:0007260) | 2.19172730 |
| 88 | Nephronophthisis (HP:0000090) | 2.17241029 |
| 89 | Esophageal varix (HP:0002040) | 2.15006458 |
| 90 | Malnutrition (HP:0004395) | 2.14937463 |
| 91 | Arthropathy (HP:0003040) | 2.12679390 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.11901021 |
| 93 | Glycosuria (HP:0003076) | 2.11396783 |
| 94 | Abnormality of urine glucose concentration (HP:0011016) | 2.11396783 |
| 95 | Menorrhagia (HP:0000132) | 2.10742072 |
| 96 | Amyloidosis (HP:0011034) | 2.10055459 |
| 97 | Enlarged kidneys (HP:0000105) | 2.09220037 |
| 98 | Pendular nystagmus (HP:0012043) | 2.08982408 |
| 99 | Opisthotonus (HP:0002179) | 2.08710481 |
| 100 | Cystic liver disease (HP:0006706) | 2.08273929 |
| 101 | Gingival bleeding (HP:0000225) | 2.06264122 |
| 102 | Abolished electroretinogram (ERG) (HP:0000550) | 2.05750540 |
| 103 | Pancreatitis (HP:0001733) | 2.05632282 |
| 104 | Vomiting (HP:0002013) | 2.05132535 |
| 105 | Attenuation of retinal blood vessels (HP:0007843) | 2.02709087 |
| 106 | Abnormality of the gallbladder (HP:0005264) | 1.99815754 |
| 107 | Generalized aminoaciduria (HP:0002909) | 1.99456266 |
| 108 | Thrombophlebitis (HP:0004418) | 1.98715996 |
| 109 | Poikilocytosis (HP:0004447) | 1.98352213 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 1.97635539 |
| 111 | Hydroxyprolinuria (HP:0003080) | 1.97635539 |
| 112 | Abnormal cartilage morphology (HP:0002763) | 1.97344917 |
| 113 | Late onset (HP:0003584) | 1.96439501 |
| 114 | Status epilepticus (HP:0002133) | 1.95793901 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.95469480 |
| 116 | Rickets (HP:0002748) | 1.93751872 |
| 117 | Abnormality of the renal medulla (HP:0100957) | 1.93720327 |
| 118 | Methylmalonic acidemia (HP:0002912) | 1.92781852 |
| 119 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.92147772 |
| 120 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91893824 |
| 121 | Hypophosphatemic rickets (HP:0004912) | 1.88826380 |
| 122 | Blue irides (HP:0000635) | 1.86784058 |
| 123 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86729917 |
| 124 | Renal cortical cysts (HP:0000803) | 1.86597458 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.84980395 |
| 126 | Hypochromic anemia (HP:0001931) | 1.84652468 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82583572 |
| 128 | Alkalosis (HP:0001948) | 1.80432880 |
| 129 | Abnormality of vitamin metabolism (HP:0100508) | 1.79353700 |
| 130 | Hyperphosphaturia (HP:0003109) | 1.78591851 |
| 131 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.77513704 |
| 132 | Elevated hepatic transaminases (HP:0002910) | 1.76753443 |
| 133 | Medial flaring of the eyebrow (HP:0010747) | 1.75313355 |
| 134 | Hypothermia (HP:0002045) | 1.74161441 |
| 135 | Hyperglycemia (HP:0003074) | 1.74072669 |
| 136 | Nephritis (HP:0000123) | 1.72492874 |
| 137 | Acute encephalopathy (HP:0006846) | 1.72247751 |
| 138 | Keratoconus (HP:0000563) | 1.70264026 |
| 139 | Increased corneal curvature (HP:0100692) | 1.70264026 |
| 140 | Tubular atrophy (HP:0000092) | 1.68486179 |
| 141 | Inability to walk (HP:0002540) | 1.63148328 |
| 142 | Male pseudohermaphroditism (HP:0000037) | 1.62337671 |
| 143 | Congenital hepatic fibrosis (HP:0002612) | 1.61127567 |
| 144 | 3-Methylglutaconic aciduria (HP:0003535) | 1.60008621 |
| 145 | Methylmalonic aciduria (HP:0012120) | 1.59224206 |
| 146 | Cerebral palsy (HP:0100021) | 1.58023859 |
| 147 | Dyskinesia (HP:0100660) | 1.55465387 |
| 148 | Sclerocornea (HP:0000647) | 1.53738733 |
| 149 | Large for gestational age (HP:0001520) | 1.52265059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.10183856 |
| 2 | FGFR4 | 4.59724627 |
| 3 | ERN1 | 4.34033949 |
| 4 | SIK1 | 4.21235238 |
| 5 | TLK1 | 3.74330586 |
| 6 | ADRBK2 | 3.15513064 |
| 7 | INSRR | 3.13469089 |
| 8 | ERBB4 | 3.00226734 |
| 9 | MAP4K2 | 2.85453231 |
| 10 | TAOK3 | 2.84678237 |
| 11 | WNK3 | 2.74335149 |
| 12 | BMPR1B | 2.70659760 |
| 13 | MAP2K4 | 2.59391178 |
| 14 | NUAK1 | 2.55769858 |
| 15 | ZAK | 2.23801871 |
| 16 | PKN2 | 2.23606444 |
| 17 | MST1R | 2.14818843 |
| 18 | ACVR1B | 2.09256137 |
| 19 | WNK4 | 1.89384492 |
| 20 | MAPK11 | 1.86789609 |
| 21 | LATS1 | 1.85384654 |
| 22 | FLT3 | 1.84486838 |
| 23 | OXSR1 | 1.79327788 |
| 24 | CASK | 1.70130904 |
| 25 | TRIB3 | 1.69411715 |
| 26 | TNIK | 1.66908605 |
| 27 | TYK2 | 1.65247743 |
| 28 | ABL2 | 1.57915216 |
| 29 | CAMKK2 | 1.56932189 |
| 30 | FGFR2 | 1.56120257 |
| 31 | MAPK13 | 1.52969841 |
| 32 | FRK | 1.50346545 |
| 33 | PIK3CG | 1.49001655 |
| 34 | DAPK2 | 1.44894369 |
| 35 | PTK6 | 1.41624764 |
| 36 | TXK | 1.39353194 |
| 37 | TRIM28 | 1.34949455 |
| 38 | GRK6 | 1.32762429 |
| 39 | NEK9 | 1.30848826 |
| 40 | MAP3K7 | 1.26530798 |
| 41 | MAP3K4 | 1.26392035 |
| 42 | JAK2 | 1.23980669 |
| 43 | KDR | 1.19185954 |
| 44 | NTRK3 | 1.13278610 |
| 45 | MAP2K3 | 1.12411561 |
| 46 | STK39 | 1.11934279 |
| 47 | PINK1 | 1.10894327 |
| 48 | PRKAA2 | 1.09107256 |
| 49 | ADRBK1 | 1.07195690 |
| 50 | ERBB2 | 1.06714444 |
| 51 | MAP3K14 | 1.06498240 |
| 52 | MAPK4 | 1.04798646 |
| 53 | TNK2 | 1.04538264 |
| 54 | DYRK2 | 1.02692577 |
| 55 | JAK1 | 0.99501741 |
| 56 | TBK1 | 0.98867527 |
| 57 | PRKCZ | 0.97586415 |
| 58 | MAP3K3 | 0.95429272 |
| 59 | MAPK15 | 0.94880779 |
| 60 | PRKCE | 0.92552183 |
| 61 | MAPK12 | 0.90777658 |
| 62 | MAP3K10 | 0.90506007 |
| 63 | STK16 | 0.88645861 |
| 64 | MET | 0.87049938 |
| 65 | STK38L | 0.85596029 |
| 66 | MARK1 | 0.82133379 |
| 67 | KIT | 0.80528131 |
| 68 | EPHB1 | 0.79924551 |
| 69 | PRKACG | 0.77891308 |
| 70 | MAP2K6 | 0.77737909 |
| 71 | CDK6 | 0.77522474 |
| 72 | IKBKB | 0.77378021 |
| 73 | CAMK2G | 0.76094709 |
| 74 | MAP3K11 | 0.75577591 |
| 75 | TGFBR1 | 0.74170478 |
| 76 | MUSK | 0.73816916 |
| 77 | MKNK2 | 0.73790685 |
| 78 | MAP2K7 | 0.73596266 |
| 79 | CSK | 0.72844221 |
| 80 | TEC | 0.70943913 |
| 81 | VRK1 | 0.70616634 |
| 82 | MST4 | 0.70227815 |
| 83 | MAPK7 | 0.69618842 |
| 84 | TIE1 | 0.68962393 |
| 85 | DYRK1B | 0.67888986 |
| 86 | FGFR3 | 0.67781635 |
| 87 | TAOK2 | 0.67559022 |
| 88 | MAPKAPK3 | 0.66501759 |
| 89 | SGK3 | 0.66426347 |
| 90 | BRSK2 | 0.66158510 |
| 91 | PRKACA | 0.65853645 |
| 92 | EPHA3 | 0.65508715 |
| 93 | PHKG2 | 0.65349000 |
| 94 | PHKG1 | 0.65349000 |
| 95 | TGFBR2 | 0.63135332 |
| 96 | GSK3A | 0.63059710 |
| 97 | EPHA4 | 0.62663856 |
| 98 | CSF1R | 0.61350152 |
| 99 | PRKAA1 | 0.60132048 |
| 100 | PLK2 | 0.59613327 |
| 101 | PNCK | 0.58343267 |
| 102 | PRKG1 | 0.57422911 |
| 103 | PTK2 | 0.55730990 |
| 104 | RIPK1 | 0.55580047 |
| 105 | GRK7 | 0.54868727 |
| 106 | IKBKE | 0.52722099 |
| 107 | FER | 0.52450946 |
| 108 | STK11 | 0.51679621 |
| 109 | PDPK1 | 0.51677751 |
| 110 | CSNK1G1 | 0.50728446 |
| 111 | PRKCQ | 0.50450205 |
| 112 | IGF1R | 0.50422749 |
| 113 | IRAK1 | 0.50150620 |
| 114 | NLK | 0.49994480 |
| 115 | GRK1 | 0.49665507 |
| 116 | NTRK2 | 0.49268074 |
| 117 | PTK2B | 0.49236787 |
| 118 | MAP3K5 | 0.48992208 |
| 119 | PRKCG | 0.47730008 |
| 120 | SGK2 | 0.47365594 |
| 121 | RET | 0.47222326 |
| 122 | CSNK1A1 | 0.46603481 |
| 123 | CSNK1D | 0.45591037 |
| 124 | ERBB3 | 0.45329819 |
| 125 | CDK19 | 0.44583297 |
| 126 | CAMK2A | 0.42729786 |
| 127 | CHUK | 0.42709397 |
| 128 | MAP2K1 | 0.41607554 |
| 129 | BCR | 0.40839634 |
| 130 | PKN1 | 0.40590448 |
| 131 | EIF2AK3 | 0.39910181 |
| 132 | PRKCI | 0.39365418 |
| 133 | MAP3K6 | 0.39347190 |
| 134 | LATS2 | 0.39336397 |
| 135 | IRAK3 | 0.39096276 |
| 136 | CSNK1G2 | 0.38606078 |
| 137 | CAMK1D | 0.38360000 |
| 138 | CAMK1 | 0.38166236 |
| 139 | AKT3 | 0.37996974 |
| 140 | EGFR | 0.37657344 |
| 141 | RPS6KA5 | 0.37366064 |
| 142 | MAP3K13 | 0.36809580 |
| 143 | PLK4 | 0.36692109 |
| 144 | ICK | 0.36136449 |
| 145 | SGK494 | 0.35994310 |
| 146 | SGK223 | 0.35994310 |
| 147 | STK3 | 0.35603270 |
| 148 | PDK2 | 0.35367618 |
| 149 | PRKCA | 0.34072352 |
| 150 | PDK3 | 0.33916602 |
| 151 | PDK4 | 0.33916602 |
| 152 | PAK3 | 0.33868350 |
| 153 | PRKACB | 0.33783984 |
| 154 | CDK4 | 0.33406905 |
| 155 | DYRK1A | 0.33382090 |
| 156 | PDK1 | 0.33298273 |
| 157 | ITK | 0.32831966 |
| 158 | CAMK4 | 0.31652124 |
| 159 | CSNK1G3 | 0.30792952 |
| 160 | MTOR | 0.30251658 |
| 161 | PIK3CA | 0.29034216 |
| 162 | ABL1 | 0.25229465 |
| 163 | BMX | 0.24844363 |
| 164 | PBK | 0.24792422 |
| 165 | CSNK1A1L | 0.22948947 |
| 166 | MAP3K1 | 0.22863195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54666453 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.60518156 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49878824 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44911704 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06921043 |
| 6 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.84187588 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.67622013 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.51476630 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49323845 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.48011380 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47501217 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38115144 |
| 13 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.36798294 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34517548 |
| 15 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.28796314 |
| 16 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.26574789 |
| 17 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.23965355 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09437524 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.02112382 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.92780902 |
| 21 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.90266426 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90143850 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83288039 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77674816 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75900824 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70304047 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68202006 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64395961 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64175791 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60369704 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58597963 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54861054 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.53917701 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48437101 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45091862 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41407387 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38911774 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35519103 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31793258 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30179799 |
| 41 | * Caffeine metabolism_Homo sapiens_hsa00232 | 1.21004276 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20938866 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.20904002 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19290125 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17263792 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16161951 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08210216 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06073287 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04380401 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99879758 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98059301 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96461707 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94128992 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92714767 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90099437 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84632130 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80747543 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.77807990 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75735197 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 0.75357915 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74416921 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73774503 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68072695 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65511939 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64261819 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55470425 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55365083 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50589808 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49733493 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49115938 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47581710 |
| 72 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45561284 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43737621 |
| 74 | Protein export_Homo sapiens_hsa03060 | 0.41922440 |
| 75 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35869734 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.35570154 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30990152 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30946273 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.26900032 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.26828865 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.22789479 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.22776068 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21969939 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21832205 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.20895694 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18378656 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17478196 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.16851906 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14237186 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13361488 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13040788 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.12373092 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.09905522 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.09493808 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.09376554 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08295356 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.07335214 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.05415337 |
| 99 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.04549721 |
| 100 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.02218129 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2371936 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2353514 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | -0.2308041 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2158541 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2154043 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2153098 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2120547 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | -0.2023858 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1963475 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1753553 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1675283 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1667172 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1640603 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1598956 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1512110 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1473460 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1270842 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1206111 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1007897 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0615168 |
| 121 | Insulin secretion_Homo sapiens_hsa04911 | -0.0049605 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0008595 |

